Sign in

CIK 0000109657

  • Non-accelerated filer
  • Smaller reporting company

GT Biopharma, Inc.

Sign in to watch
Ticker
GTBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
941620407
Phone
+1 800-304-9888
Business address
505 MONTGOMERY STREET, 10TH FLOOR, SAN FRANCISCO, CA, 94111
Former names
GT Biopharma, Inc., OXIS INTERNATIONAL INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-09-04 Breen Michael Martin CEO and Director Grant or award · Option to purchase Common Stock +100,000 100,000
2025-09-04 Breen Michael Martin CEO and Director Grant or award · Option to purchase Common Stock +100,000 100,000
2025-09-04 Breen Michael Martin CEO and Director Grant or award · Option to purchase Common Stock +100,000 100,000
2023-08-11 Breen Michael Martin Executive Chairman/Interim CEO Grant or award +200,000 $0.29 $57K 856,218
2023-04-11 Breen Michael Martin Executive Chairman/Interim CEO Purchase +50,000 $0.50 $25K 656,218
2023-01-27 Breen Michael Martin Exec Chairman and Interim CEO Grant or award · Option to purchase Common Stock +500,000 500,000
2022-07-15 Breen Michael Martin Exec. Chair. and Interim CEO Grant or award +278,058 606,218
2022-07-15 Breen Michael Martin Exec. Chair. and Interim CEO Grant or award · Option to purchase Common Stock +50,000 50,000
2021-02-25 Breen Michael Martin Director Conversion +40,243 $3.40 $137K 318,301
2021-02-25 Breen Michael Martin Director Conversion +9,859 $3.40 $34K 328,160
2021-02-25 Breen Michael Martin Director Conversion · 10% Senior Convertible Debenture −100,000 0
2021-02-25 Breen Michael Martin Director Conversion · 10% Senior Convertible Debenture −30,000 0
2021-02-16 Breen Michael Martin Director Grant or award +278,058 278,058
2021-02-16 Breen Michael Martin Director Grant or award · Option to purchase Common Stock +50,000 50,000

Page 1 of 1 · 14 trades